ResMed Inc (RMD)
243.60
+2.05
(+0.85%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.35
(+0.55%)
After-Hours: 20:00
ResMed Enterprise Value: 36.01B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 36.01B |
| November 20, 2024 | 35.71B |
| November 19, 2024 | 35.21B |
| November 18, 2024 | 35.40B |
| November 15, 2024 | 34.71B |
| November 14, 2024 | 34.22B |
| November 13, 2024 | 34.81B |
| November 12, 2024 | 36.54B |
| November 11, 2024 | 36.76B |
| November 08, 2024 | 37.30B |
| November 07, 2024 | 36.74B |
| November 06, 2024 | 36.31B |
| November 05, 2024 | 36.32B |
| November 04, 2024 | 36.01B |
| November 01, 2024 | 36.11B |
| October 31, 2024 | 35.84B |
| October 30, 2024 | 35.93B |
| October 29, 2024 | 36.13B |
| October 28, 2024 | 36.48B |
| October 25, 2024 | 37.84B |
| October 24, 2024 | 35.34B |
| October 23, 2024 | 35.10B |
| October 22, 2024 | 35.48B |
| October 21, 2024 | 35.49B |
| October 18, 2024 | 35.48B |
| Date | Value |
|---|---|
| October 17, 2024 | 35.42B |
| October 16, 2024 | 35.23B |
| October 15, 2024 | 35.36B |
| October 14, 2024 | 35.58B |
| October 11, 2024 | 35.55B |
| October 10, 2024 | 35.17B |
| October 09, 2024 | 35.04B |
| October 08, 2024 | 34.90B |
| October 07, 2024 | 34.35B |
| October 04, 2024 | 34.59B |
| October 03, 2024 | 35.25B |
| October 02, 2024 | 35.31B |
| October 01, 2024 | 35.29B |
| September 30, 2024 | 36.08B |
| September 27, 2024 | 35.55B |
| September 26, 2024 | 36.07B |
| September 25, 2024 | 35.80B |
| September 24, 2024 | 36.74B |
| September 23, 2024 | 36.64B |
| September 20, 2024 | 36.46B |
| September 19, 2024 | 36.17B |
| September 18, 2024 | 35.44B |
| September 17, 2024 | 37.33B |
| September 16, 2024 | 37.46B |
| September 13, 2024 | 37.04B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.63B
Minimum
Mar 20 2020
43.68B
Maximum
Sep 08 2021
31.04B
Average
31.47B
Median
Nov 05 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Globus Medical Inc | 11.30B |
| Abbott Laboratories | 210.81B |
| Haemonetics Corp | 5.216B |
| Becton Dickinson & Co | 83.11B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 311.36M |
| Revenue (Quarterly) | 1.225B |
| Total Expenses (Quarterly) | 837.20M |
| EPS Diluted (Quarterly) | 2.11 |
| Gross Profit Margin (Quarterly) | 58.57% |
| Profit Margin (Quarterly) | 25.43% |
| Earnings Yield | 3.10% |
| Operating Earnings Yield | 4.12% |
| Normalized Earnings Yield | 3.254 |